Peter Jarrett
Chief Tech/Sci/R&D Officer chez OCULAR THERAPEUTIX, INC.
Profil
Peter Jarrett is currently the Chief Technical Officer at Ocular Therapeutix, Inc. He previously worked as the Head of Research & Development at Wyeth Holdings LLC.
From 1993 to 2001, he served as the Vice President of Research & Development at Focal, Inc. Following that, he held the position of Vice President of Biomaterials R&D at Genzyme Corp.
from 2001 to 2007.
Dr. Jarrett obtained his undergraduate degree from Connecticut College and his doctorate from The Institute of Materials Science.
Postes actifs de Peter Jarrett
| Sociétés | Poste | Début |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Chief Tech/Sci/R&D Officer | 01/01/2007 |
Anciens postes connus de Peter Jarrett
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2007 |
Focal, Inc.
 Focal, Inc. Chemicals: SpecialtyProcess Industries Focal Inc, is a developing biodegradable interventional therapeutic products to treat serious local diseases. The company products consist of a biodegradable polymer system that can deliver drugs locally to the site of disease and/or act as a physical barrier. Other Focal research & development programs include polymer and drug delivery products to: prevent adhesions (internal scar tissue) following surgery; serve as surgical sealants; and deliver drugs locally for other indications. | Chief Tech/Sci/R&D Officer | 01/01/2001 |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Chief Tech/Sci/R&D Officer | - |
Formation de Peter Jarrett
| Connecticut College | Undergraduate Degree |
| The Institute of Materials Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Focal Inc, is a developing biodegradable interventional therapeutic products to treat serious local diseases. The company products consist of a biodegradable polymer system that can deliver drugs locally to the site of disease and/or act as a physical barrier. Other Focal research & development programs include polymer and drug delivery products to: prevent adhesions (internal scar tissue) following surgery; serve as surgical sealants; and deliver drugs locally for other indications. | Process Industries |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
